Northland Securities Downgrades NxStage Medical (NXTM) to Market Perform
Tweet Send to a FriendGet Alerts NXTM Hot Sheet
Price: $13.56 +1.27%
Rating Summary:
8 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 24 | New: 24
Rating Summary:
8 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 24 | New: 24
Trade NXTM Now!
Northland Securities downgraded NxStage Medical (NASDAQ: NXTM) from Outperform to Market Perform with a price target of $12.00 (from $18.00).
For an analyst ratings summary and ratings history on NxStage Medical click here. For more ratings news on NxStage Medical click here.
Shares of NxStage Medical closed at $12.14 yesterday, with a 52 week range of $10.15-$21.87.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on NxStage Medical click here. For more ratings news on NxStage Medical click here.
Shares of NxStage Medical closed at $12.14 yesterday, with a 52 week range of $10.15-$21.87.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: UBS Downgrades Carnival (CCL) to Neutral; Worst May Not Be Behind
- Jefferies Boosts Price Target on TiVo (TIVO)
- Roth Capital Downgrades Acquity Group (AQ) to Neutral
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
Northland Securities
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
